Balstilimab

LEXINGTON, Mass., April 3, 2026 Agenus Inc. has announced that new data from its Phase II clinical study evaluating...

LEXINGTON, Mass., Feb. 19, 2026 — Agenus Inc. announced new translational and clinical biomarker findings demonstrating survival stratification in...